Although these RTKs are known to play a key role in oncogenic transformation, carcinogenesis and tumor invasiveness, there is little information about the relationships between EGFR, HER2 and c-Met in cervical adenocarcinoma. The gene discussed is ERBB2; the disease is neoplasm.